Personalizing Cardiometabolic Drug Therapies for Racial and Ethnic Minorities
Certain populations of ethnic and racial groups respond differently to many classes of drugs. While there are many factors that can influence drug response, one area that has emerged as helpful to clinicians in recent years is pharmacogenomics (PGx). Using PGx strategies to improve therapeutic outcomes for ethnic and racial populations is the topic of […]
